Novartis and IBM have announced a partnership this week through IBM Watson’s artificial intelligence abilities and Novartis’ breast cancer treatment. Researchers will have the ability to use IBM Watson, along with patient data, to better understand and forecast real-world outcomes of breast cancer treatments. The collaboration seeks to help oncologists make better informed decisions regarding care and long-term treatment alongside patients. Read the full press release here.